We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
INTEGRA BIOSCIENCES AG

Download Mobile App




In Other News

Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to support earlier Alzheimer’s and dementia diagnosis in the UK. Read more
24 Sep 2026 | Industry
Image: Galleri is designed to detect cancer-specific methylation patterns across multiple cancer types before symptoms appear, including cancers without recommended screening (Photo courtesy of GRAIL)

Multi-Cancer Early Detection Test Wins FDA Panel Backing for Approval

GRAIL’s Galleri MCED test received a favorable FDA advisory panel vote supporting its Premarket Approval (PMA) application. Read more
24 Sep 2026 | Industry
Image: The findings reveal that individuals exposed to Borrelia burgdorferi, the bacterium that causes Lyme disease, are more than four times as likely to have antibodies against other tick-borne pathogens (Image Credit: Shutterstock)

Study Finds Frequent Overlap in Antibodies to Lyme and Other Tick-Borne Pathogens

New data show nearly one-third of Lyme-seropositive patients also have antibodies to other tick-borne pathogens. Read more
23 Sep 2026 | Microbiology
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

A new point-of-care blood test gains CE mark to detect stroke and flag large-vessel occlusion. Read more
23 Sep 2026 | Clinical Chem.
Image: Graphical Abstract (Turner N, Keam S, Abdel-Wahab N, et al. B cell-guided inflammatory cascade perpetuates ICI-mediated colitis. Cell Reports (2026). doi:10.1016/j.celrep.2026.117969)

Blood Biomarker May Predict Colitis Risk in Checkpoint Inhibitor Therapy

New findings show that blood-based B-cell activity helps predict immunotherapy-related colitis risk. Read more
23 Sep 2026 | Immunology
Image: GRAIL’s Galleri test uses machine learning to analyze cfDNA patterns for cancer signals and predict their likely location to guide further evaluation.

Multi-Cancer Blood Test Expands Detection to Cancers Lacking Routine Screening Options

New findings show that adding a MCED blood test to standard screening increased early cancer detection 6.5-fold with 99.6% specificity. Read more
23 Sep 2026 | Clinical Chem.
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

A new blood-based tumor DNA test distinguishes malignant from benign nerve sheath tumors and supports earlier monitoring in neurofibromatosis. Read more
23 Sep 2026 | Molecular Diagnostics
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

New data show infant gut microbiome maturation trajectories stratify risk of type 1 diabetes and early autoimmune activity. Read more
22 Sep 2026 | Microbiology
Image: cCMV screening is not universal in U.S. newborns, yet over 40% of children who develop related hearing loss initially pass newborn hearing screening, highlighting the need for broader approaches (Image Credit: iStock)

Expanded Newborn Screening Program Increases Detection of Congenital Cytomegalovirus

A system-wide newborn cCMV screening program using swab and urine tests boosts detection 2.5-fold and enables earlier care. Read more
22 Sep 2026 | Microbiology
Image Credit: Adobe Stock

FDA Breakthrough-Designated Urine Panel Aims to Shorten Pathogen and Susceptibility Testing

A direct-from-specimen urine ID/AST panel received FDA Breakthrough status to support same-day organism identification and susceptibility testing. Read more
22 Sep 2026 | Microbiology
Image: Volcano plot of overrepresented genes in H10544. (Zhichen Zhu et al., Antimicrobial Agents and Chemotherapy (2026). DOI: 10.1128/aac.00506-26)

Genetic Studies Uncover Mechanisms Driving Drug Resistance in Superbugs

New findings map K. pneumoniae drug resistance, reveal trade-offs that restore last-line treatment sensitivity, and support targeted prevention. Read more
22 Sep 2026 | Microbiology
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

New findings for Natera's Signatera molecular residual disease (MRD) test were presented at the IASLC 2026 World Conference. Read more
22 Sep 2026 | Molecular Diagnostics
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Siemens Healthineers and Novo have partnered to advance MASLD and MASH care through earlier assessment and broader access to noninvasive testing. Read more
22 Sep 2026 | Industry

Channels

Clinical Chemistry

view channel
Blood Test Patterns Improve Cancer Risk Assessment in Primary Care
Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection
Machine Learning Supports Targeted Screening for Elevated Lipoprotein(a)
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Electronic Genome Mapping Reveals Structural Abnormalities in Hematologic Malign...
Rare Genetic Variant Linked to Dramatically Higher Lung Cancer Risk
Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory...
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Hematology

view channel
New Automated Hemostasis Systems Become Available Across US Laboratories
Variation in AML Residual Disease Testing Prompts Push for Standardization
Hidden Molecular Mechanism Behind HIT Blood-Clotting Disorder Revealed
Image Credit: American Society of Hematology

Updated Ferritin Thresholds Improve Detection of Iron Deficiency

Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read more

Immunology

view channel
New Cellular Map May Help Predict Crohn’s Disease Course in Children
Temporal Immune Profiling Reveals How Sepsis States Change Over Time
Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID...
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Infant Skin Microbiome Show Links to Later Eczema and Food Allergies
Diagnostic Stewardship Guide Targets Testing Overuse and Hospital Cost Pressures
Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard ...
Machine Learning Cytology Tool Improves Cancer Cell Identification
Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous...
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic ...
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Sputum-Based Lung Cancer Test Technology Granted Hong Kong Patent
Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities
Unilabs Expands Digital Pathology Across European Network with Proscia Platform
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
Industry
BioResearch
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
ADLM WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica

 

ADLM Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE